Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L10a pseudogene 1 (RPL10AP1) is a processed pseudogene related to the ribosomal protein L10a gene. It does not encode a functional protein and is not considered a therapeutic target. Like other pseudogenes, it may have potential regulatory effects on parental gene expression by acting as a competing endogenous RNA or miRNA sponge, but there is no direct evidence of such roles for RPL10AP1 specifically. RPL10AP1 is most important as a non-coding genomic DNA sequence with sequence similarity to the protein-coding RPL10A gene, contributing to the genomic landscape of pseudogenes in humans[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L10a pseudogene 1 (RPL10AP1).